Development and Characterization of Different Dosage Forms of Nifedipine/Indomethacin Fixed-Dose Combinations.

[1]  M. Repka,et al.  Formulation development of loratadine immediate- release tablets using hot-melt extrusion and 3D printing technology , 2022, Journal of Drug Delivery Science and Technology.

[2]  D. Serrano,et al.  Understanding Direct Powder Extrusion for Fabrication of 3D Printed Personalised Medicines: A Case Study for Nifedipine Minitablets , 2021, Pharmaceutics.

[3]  N. Nyamweya.  Applications of polymer blends in drug delivery , 2021, Future Journal of Pharmaceutical Sciences.

[4]  M. Repka,et al.  Development of a quantitative method to evaluate the printability of filaments for fused deposition modeling 3D printing. , 2020, International journal of pharmaceutics.

[5]  F. Bolás-Fernández,et al.  Oral Fixed-Dose Combination Pharmaceutical Products: Industrial Manufacturing Versus Personalized 3D Printing , 2020, Pharmaceutical Research.

[6]  M. Roberts,et al.  Challenges and innovations of drug delivery in older age , 2018, Advanced drug delivery reviews.

[7]  Xin Feng,et al.  Pharmaceutical Additive Manufacturing: a Novel Tool for Complex and Personalized Drug Delivery Systems , 2018, AAPS PharmSciTech.

[8]  Changxue Xu,et al.  Multi‐purposable filaments of HPMC for 3D printing of medications with tailored drug release and timed‐absorption , 2018, International journal of pharmaceutics.

[9]  I. Navarro-Millán,et al.  Cardiovascular co-morbidity in patients with rheumatoid arthritis: a narrative review of risk factors, cardiovascular risk assessment and treatment , 2018, BMC Rheumatology.

[10]  L Van Hoorebeke,et al.  3D printing of high drug loaded dosage forms using thermoplastic polyurethanes. , 2018, International journal of pharmaceutics.

[11]  Michael A Repka,et al.  Coupling 3D printing with hot-melt extrusion to produce controlled-release tablets. , 2017, International journal of pharmaceutics.

[12]  W. Brett Caldwell,et al.  Multiparticulate Technologies for Fixed-Dose Combinations , 2017 .

[13]  M. Khan,et al.  A new chapter in pharmaceutical manufacturing: 3D‐printed drug products☆, ☆☆ , 2017, Advanced drug delivery reviews.

[14]  S. Majumdar,et al.  Hot melt extrusion as an approach to improve solubility, permeability and oral absorption of a psychoactive natural product, piperine , 2016, The Journal of pharmacy and pharmacology.

[15]  Lawrence X. Yu,et al.  Emerging technology: A key enabler for modernizing pharmaceutical manufacturing and advancing product quality. , 2016, International journal of pharmaceutics.

[16]  Hugh Smyth,et al.  3D Printing technologies for drug delivery: a review , 2016, Drug development and industrial pharmacy.

[17]  Jonathan Goole,et al.  3D printing in pharmaceutics: A new tool for designing customized drug delivery systems. , 2016, International journal of pharmaceutics.

[18]  M. Repka,et al.  Hot-Melt Extrusion: from Theory to Application in Pharmaceutical Formulation , 2015, AAPS PharmSciTech.

[19]  Ronan Daly,et al.  Inkjet printing for pharmaceutics - A review of research and manufacturing. , 2015, International journal of pharmaceutics.

[20]  S. Majumdar,et al.  Influence of Molecular Weight of Carriers and Processing Parameters on the Extrudability, Drug Release, and Stability of Fenofibrate Formulations Processed by Hot-Melt Extrusion. , 2015, Journal of drug delivery science and technology.

[21]  T. De Beer,et al.  Co-extruded solid solutions as immediate release fixed-dose combinations. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[22]  M. Alexander,et al.  Desktop 3D printing of controlled release pharmaceutical bilayer tablets. , 2014, International journal of pharmaceutics.

[23]  H. Wen,et al.  Formulation design, challenges, and development considerations for fixed dose combination (FDC) of oral solid dosage forms , 2013, Pharmaceutical development and technology.

[24]  A. Mohammed,et al.  The impact of ageing on the barriers to drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[25]  A. Mitra,et al.  Challenges and Opportunities in Achieving Bioequivalence for Fixed-Dose Combination Products , 2012, The AAPS Journal.

[26]  J. Singh,et al.  Prediction of in vitro Drug Release Mechanisms from Extended Release Matrix Tablets using SSR/R2 Technique , 2011 .

[27]  Sandip B. Tiwari,et al.  Applications of Complementary Polymers in HPMC Hydrophilic Extended Release Matrices , 2009 .

[28]  T. Pal,et al.  Formulation and In Vitro Studies of a Fixed-Dose Combination of a Bilayer Matrix Tablet Containing Metformin HCl as Sustained Release and Glipizide as Immediate Release , 2008 .

[29]  Charles E. Martin,et al.  Pharmaceutical Applications of Hot-Melt Extrusion: Part II , 2007, Drug development and industrial pharmacy.

[30]  Panos Macheras,et al.  A century of dissolution research: from Noyes and Whitney to the biopharmaceutics classification system. , 2006, International journal of pharmaceutics.

[31]  A. Salvetti,et al.  Nifedipine interactions in hypertensive patients , 1990, Cardiovascular Drugs and Therapy.

[32]  J. Aronson.  Medication errors resulting from the confusion of drug names , 2004 .

[33]  Stephen W. Hoag,et al.  Assessment of Polymer-Polymer Interactions in Blends of HPMC and Film Forming Polymers by Modulated Temperature Differential Scanning Calorimetry , 2000, Pharmaceutical Research.

[34]  Feng Zhang,et al.  Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion. , 2002, Biomaterials.

[35]  Md. Selim Reza,et al.  Development of theophylline sustained release dosage form based on Kollidon SR. , 2002, Pakistan journal of pharmaceutical sciences.

[36]  Trefor Owen Morgan,et al.  Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril. , 2000, American journal of hypertension.

[37]  J. Polónia,et al.  Influence of non-steroidal anti-inflammatory drugs on renal function and 24 h ambulatory blood pressure-reducing effects of enalapril and nifedipine gastrointestinal therapeutic system in hypertensive patients , 1995, Journal of hypertension.

[38]  Nicholas A. Peppas,et al.  A simple equation for description of solute release I. Fickian and non-fickian release from non-swellable devices in the form of slabs, spheres, cylinders or discs , 1987 .

[39]  N. Peppas,et al.  Mechanisms of solute release from porous hydrophilic polymers , 1983 .

[40]  C. Dollery,et al.  Attenuation of hypotensive effect of propranolol and thiazide diuretics by indomethacin. , 1980, British medical journal.

[41]  C. Stetler.  Fixed Combination Drugs , 1971, Science.

[42]  A. W. Hixson,et al.  Dependence of Reaction Velocity upon surface and Agitation , 1931 .